Clinic
Express Healthcare, LLC
Express Healthcare, LLC was paid $6.68M by Medicaid between Feb 2018 and Dec 2024, across 29 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 38% of everything it billed.
33Billing provider infoEXPRESS HEALTHCARE, LLC
BERWYN HEIGHTS, MD 20740
BERWYN HEIGHTS, MD 20740
33aNPI1598994733assigned 07/09/2009
33bProvider typeUrgent Care Clinic/Center
28Total paid$6.68M
24GClaims288,780
24DCodes billed29
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Maryland
Rank by total paid#10 of 114
Median peer was paid$654K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 95 | $1K | |
| 2019 | 13 | $33.80 | |
| 2020 | 10,830 | $221K | |
| 2021 | 180,656 | $4.02M | |
| 2022 | 91,594 | $2.29M | |
| 2023 | 5,075 | $145K | |
| 2024incomplete | 517 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 38% | 42,456 | 32,682 | $2.51M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 25,757 | 19,033 | $1000K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14% | 22,411 | 17,342 | $916K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 7.2% | 19,496 | 14,513 | $483K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 5.6% | 40,471 | 29,145 | $377K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.0% | 40,928 | 30,014 | $331K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.9% | 3,802 | 2,467 | $329K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.6% | 32,429 | 24,632 | $242K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.9% | 3,182 | 2,315 | $130K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 3,838 | 2,767 | $81K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.0% | 2,532 | 2,034 | $70K |
| 87428 | <1% | 1,372 | 1,148 | $54K |
17 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,486 | $48K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,020 | $40K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,081 | $20K |
| 99051 | <1% | 13,321 | $19K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 140 | $11K |
| 99000 | <1% | 17,906 | $11K | |
| 87631 | <1% | 73 | $4K | |
| 94760 | <1% | 2,242 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 88 | $2K |
| S9083 | Global fee urgent care centers | <1% | 7,548 | $1K |
| 86769 | <1% | 31 | $754.32 | |
| 99058 | <1% | 25 | $503.57 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 65 | $471.44 |
| 86328 | <1% | 17 | $463.15 | |
| 96127 | <1% | 27 | $80.07 | |
| 36416 | 0% | 19 | $0.00 | |
| 99001 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFADUL, JAMAL (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Med-Ped Health Care LLC | Berwyn Heights, MD | $1.14M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.